Buscar

Mostrando ítems 1-10 de 453

Hesperidin as a neuroprotective agent: A review of animal and clinical evidence

Hajialyani M.; Farzaei M.H.; Echeverría J.; Nabavi S.M.; Uriarte E.; Eduardo S.-S. (MDPI AG, 2019)

New therapeutic property of dimebon as a neuroprotective agent

Ustyugov A.; Shevtsova E.; Barreto G.E.; Ashraf G.M.; Bachurin S.O.; Aliev G. (Bentham Science Publishers B.V., 2018)

Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system

González-Giraldo Y.; Forero D.A.; Echeverria V.; Gonzalez J.; Ávila-Rodriguez M.; Garcia-Segura L.M.; Barreto G.E. (Elsevier Ireland Ltd, 2016)

Neuroprotection by curcumin: A review on brain delivery strategies

Askarizadeh A.; Barreto G.E.; Henney N.C.; Majeed M.; Sahebkar A. (Elsevier B.V., 2020)

Mitochondrial permeability transition pore as a suitable target for neuroprotective agents against alzheimer’s disease

Shevtsova E.F.; Vinogradova D.V.; Neganova M.E.; Avila-Rodriguez M.; Ashraf G.M.; Barreto G.E.; Bachurin S.O.; Aliev G. (Bentham Science Publishers B.V., 2017)

Neuroprotective role of hypothermia in hypoxic-ischemic brain injury: Combined therapies using estrogen

Toro-Urrego N.; Vesga-Jiménez D.J.; Herrera M.I.; Luaces J.P.; Capani F. (Bentham Science Publishers, 2019)

Neuroprotection in Synaptic Signalling During Neurological Disorders

Otero losada, Matilde Estela; Wandosell, Francisco G.; Capani, Francisco (Frontiers Media, 2021-06)

Some of the most devastating and costly conditions in the world arise from neurological andneurodegenerative disorders. About one-third of the world's population suffers from neurologicaldiseases, including Parkinson's ...

Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches

Garzón D.; Cabezas R.; Vega N.; Ávila-Rodriguez M.; Gonzalez J.; Gómez R.M.; Echeverria V.; Aliev G.; Barreto G.E. (Springer New York LLC, 2016)

Neuroprotection in hypoxic-ischemic brain injury targeting glial cells

Mucci S.; Herrera M.I.; Barreto G.E.; Kolliker-Frers R.; Capani F. (Bentham Science Publishers B.V., 2017)

Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?

Echeverria V.; Barreto G.E.; Ávila-Rodriguez M.; Tarasov V.V.; Aliev G. (Bentham Science Publishers B.V., 2017)

1
2
3
4
. . .
46